Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Spotify
SPOT
|
+$334M |
| 2 |
Alibaba
BABA
|
+$294M |
| 3 |
Service Corp International
SCI
|
+$166M |
| 4 |
Kirby Corp
KEX
|
+$147M |
| 5 |
Petrobras
PBR
|
+$141M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$450M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$424M |
| 3 |
Trip.com Group
TCOM
|
+$157M |
| 4 |
Stellantis
STLA
|
+$129M |
| 5 |
Verisk Analytics
VRSK
|
+$89.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 33.7% |
| 2 | Communication Services | 17.27% |
| 3 | Healthcare | 16.98% |
| 4 | Financials | 10.38% |
| 5 | Technology | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
United Parcel Service
UPS
$91.8B
| $21.6M | 0.03% |
221,527
+5,593
| +3% | +$606K |
|
152
Grupo Cibest SA
CIB
$21.6B
| $21.4M | 0.03% |
+562,894
| New | +$22.5M |
|
|
ADAP
153
DELISTED
Adaptimmune Therapeutics
ADAP
| $21.3M | 0.03% |
3,699,521
+281,894
| +8% | +$2.08M |
|
154
RPM International
RPM
$14.8B
| $21.1M | 0.03% |
358,701
+52,752
| +17% | +$3.23M |
|
|
MB
155
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $21M | 0.03% |
577,882
+17,850
| +3% | +$543K |
|
156
Evolent Health
EVH
$345M
| $20.6M | 0.03% |
1,030,753
+27,604
| +3% | +$639K |
|
157
Apple
AAPL
$4.51T
| $20.5M | 0.03% |
520,044
+20,544
| +4% | +$996K |
|
158
HEICO Corp
HEI
$51.4B
| $19.2M | 0.03% |
248,010
-575
| -0.2% | -$47.9K |
|
159
Yext
YEXT
$575M
| $19.2M | 0.03% |
1,293,791
+324,297
| +33% | +$5.72M |
|
160
Edison International
EIX
$26.2B
| $18.7M | 0.02% |
328,956
+113,016
| +52% | +$7.03M |
|
|
AXON
161
Axon Enterprise
AXON
$48.8B
| $16.7M | 0.02% |
+380,618
| New | +$19.7M |
|
162
Tandem Diabetes Care
TNDM
$1.33B
| $16.5M | 0.02% |
434,700
| – | – |
|
|
JT
163
DELISTED
Jianpu Technology Inc. American Depositary Shares, each representing twenty Class A Ordinary Shares
JT
| $15.5M | 0.02% |
464,965
+227,783
| +96% | +$8.54M |
|
|
ORTX
164
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $14.6M | 0.02% |
+92,500
| New | +$13.8M |
|
165
Dolby
DLB
$5.68B
| $14.5M | 0.02% |
233,877
+10,939
| +5% | +$736K |
|
166
Lindblad Expeditions
LIND
$2.23B
| $14.4M | 0.02% |
1,072,701
| – | – |
|
|
FARO
167
DELISTED
Faro Technologies
FARO
| $14.4M | 0.02% |
354,985
+12,377
| +4% | +$600K |
|
168
Cullen/Frost Bankers
CFR
$10.4B
| $14M | 0.02% |
158,901
+18,367
| +13% | +$1.79M |
|
169
M&T Bank
MTB
$36.6B
| $13.8M | 0.02% |
96,766
-7,527
| -7% | -$1.2M |
|
170
Stratasys
SSYS
$773M
| $13.7M | 0.02% |
759,891
+29,370
| +4% | +$614K |
|
|
ONC
171
BeOne Medicines Ltd
ONC
$34B
| $13.3M | 0.02% |
94,716
+12,938
| +16% | +$1.72M |
|
172
Ambarella
AMBA
$3.62B
| $13.2M | 0.02% |
377,363
+10,715
| +3% | +$379K |
|
173
Axogen
AXGN
$2.42B
| $13M | 0.02% |
636,800
+624,032
| +4,887% | +$19.5M |
|
174
Invesco Senior Income Trust
VVR
$456M
| $12.9M | 0.02% |
3,310,700
| – | – |
|
|
VAR
175
DELISTED
Varian Medical Systems, Inc.
VAR
| $12.3M | 0.02% |
108,904
-8,471
| -7% | -$969K |
|
Similar funds
Baillie Gifford & Co's Q4 2018 Portfolio in Review
As of Q4 2018, Baillie Gifford & Co held 231 positions worth $77B, down 17% from $92.6B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Baillie Gifford & Co's Q4 2018 filing shows 7 new, 131 increased, 65 reduced and 5 closed positions. Its largest new stake was Tencent Music: 8,196,089 shares worth $108M. The largest sale was TSMC, an estimated $450M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 33% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q4 2018 buy was Tencent Music: 8,196,089 shares worth $108M.
- Baillie Gifford & Co added most to Spotify in Q4 2018, an estimated $334M increase.
- Baillie Gifford & Co's biggest Q4 2018 reduction was TSMC, cutting an estimated $450M.
- Baillie Gifford & Co fully exited China Biologic Products Holdings, Inc. in Q4 2018, selling an estimated $70.6M.
- Baillie Gifford & Co's ten largest holdings make up 46% of its $77B portfolio in Q4 2018.
- Baillie Gifford & Co opened 7 new positions and closed 5 in Q4 2018.
- Baillie Gifford & Co's portfolio value fell 17% quarter-over-quarter to $77B.
Based on Baillie Gifford & Co's 13F filing for Q4 2018, filed 14 Feb 2019.